However, the clearance of plasma β2M in the kidney disease patients with chronic dialysis treatment is disrupted or disturbed, leading to an increase in the concentration of β2M up to 60 folds, reaching ~50–70 μg/mL compared with the normal concentration of 1–2 μg/mL [10,11]. The gene discussed is B2M; the disease is kidney disorder.